Clinical trials: Major Depressive Diorder
Major Depressive Disorder
Eealy Improvement Predicts Antidepressants Response in Adults With Major Depression Disorder
Early improvemrnt, decreased 20% in the 17 items of Hamilton Depression Rating Scale (HAMD-17) at the second week of the treatment of major depression disorder (MDD), can arguably predict the remission at the 12th week.
- Trial name
- NCT03230682
- Testing
- antidepressant
- Where
- China
- Volunteers
- 80 people
- Sponsor
- Huashan Hospital
Bipolar Disorder (BD), Major Depressive Diorder
Stress Management With Real-time Bio-signal Biofeedback
The goal of this clinical trial is to learn if the real-time bio-signal monitoring device (Neuronicle FX2 device), combined with mindfulness-based cognitive therapy (MBCT), helps manage stress and improves symptoms of mood…
- Trial name
- NCT06616116
- Testing
- Biosignal feedback
- Where
- South Korea
- Volunteers
- 140 people
- Sponsor
- Seoul National University Hospital
Major Depressive Diorder
Efficacy and Safety of DTMS in Adolescent Major Depressive Disorder
The goal of this randomized controlled trial is to explore the efficacy and safety of two different dTMS devices in adolescent depression: deep TMS H1 coil and deep TMS H7 coil.
- Trial name
- NCT06728280
- Testing
- deep transcranial magnetic stimulation with H1coil, deep transcranial magnetic stimulation with H7 coil
- Where
- 2 sites in China
- Volunteers
- 100 people
- Sponsor
- Zhifen Liu